Selected research
Market Outlook & Growth Opportunities
Global Medical AI-assisted Diagnosis Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical AI-assisted Diagnosis Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical AI-assisted Diagnosis Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical AI-assisted Diagnosis Solution market include Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Lepu Medical, Infervision and NeuMiva, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical AI-assisted Diagnosis Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical AI-assisted Diagnosis Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical AI-assisted Diagnosis Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical AI-assisted Diagnosis Solution market.
Medical AI-assisted Diagnosis Solution Segment by Company
Sense Time
United Imaging
Huiying Medical
Yizhun
BioMind
Shukun
Lepu Medical
Infervision
NeuMiva
Baidu Lingyi
Tencent Health
Deepwise
VoxelCloud
Wision
ZHENHEALTH
G K Healthcare
Medical AI-assisted Diagnosis Solution Segment by Type
Lung AI-assisted Diagnosis
Bone AI-assisted Diagnosis
Cardiovascular and Cerebrovascular AI-assisted Diagnosis
Breast AI-assisted Diagnosis
Ophthalmic AI-assisted Diagnosis
Other AI-assisted Diagnosis
Medical AI-assisted Diagnosis Solution Segment by Application
Hospital
Clinic
Imaging Center
Medical AI-assisted Diagnosis Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical AI-assisted Diagnosis Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical AI-assisted Diagnosis Solution key companies, revenue, market share, and recent developments.
3. To split the Medical AI-assisted Diagnosis Solution breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical AI-assisted Diagnosis Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical AI-assisted Diagnosis Solution significant trends, drivers, influence factors in global and regions.
6. To analyze Medical AI-assisted Diagnosis Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical AI-assisted Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical AI-assisted Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical AI-assisted Diagnosis Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical AI-assisted Diagnosis Solution industry.
Chapter 3: Detailed analysis of Medical AI-assisted Diagnosis Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical AI-assisted Diagnosis Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical AI-assisted Diagnosis Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung AI-assisted Diagnosis
- Bone AI-assisted Diagnosis
- Cardiovascular and Cerebrovascular AI-assisted Diagnosis
- Breast AI-assisted Diagnosis
- Ophthalmic AI-assisted Diagnosis
- Other AI-assisted Diagnosis
Applications
- Hospital
- Clinic
- Imaging Center
Companies covered
- Sense Time
- United Imaging
- Huiying Medical
- Yizhun
- BioMind
- Shukun
- Lepu Medical
- Infervision
- NeuMiva
- Baidu Lingyi
- Tencent Health
- Deepwise
- VoxelCloud
- Wision
- ZHENHEALTH
- G K Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical AI-assisted Diagnosis Solution Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical AI-assisted Diagnosis Solution Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical AI-assisted Diagnosis Solution Market Dynamics
- 2.1 Medical AI-assisted Diagnosis Solution Industry Trends
- 2.2 Medical AI-assisted Diagnosis Solution Industry Drivers
- 2.3 Medical AI-assisted Diagnosis Solution Industry Opportunities and Challenges
- 2.4 Medical AI-assisted Diagnosis Solution Industry Restraints
3 Medical AI-assisted Diagnosis Solution Market by Company
- 3.1 Global Medical AI-assisted Diagnosis Solution Company Revenue Ranking in 2025
- 3.2 Global Medical AI-assisted Diagnosis Solution Revenue by Company (2021-2026)
- 3.3 Global Medical AI-assisted Diagnosis Solution Company Ranking (2024-2026)
- 3.4 Global Medical AI-assisted Diagnosis Solution Company Manufacturing Base and Headquarters
- 3.5 Global Medical AI-assisted Diagnosis Solution Company Product Type and Application
- 3.6 Global Medical AI-assisted Diagnosis Solution Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical AI-assisted Diagnosis Solution Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical AI-assisted Diagnosis Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical AI-assisted Diagnosis Solution Market by Type
- 4.1 Medical AI-assisted Diagnosis Solution Type Introduction
- 4.1.1 Lung AI-assisted Diagnosis
- 4.1.2 Bone AI-assisted Diagnosis
- 4.1.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis
- 4.1.4 Breast AI-assisted Diagnosis
- 4.1.5 Ophthalmic AI-assisted Diagnosis
- 4.1.6 Other AI-assisted Diagnosis
- 4.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Type
- 4.2.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Type (2021-2032)
- 4.2.3 Global Medical AI-assisted Diagnosis Solution Sales Value Share by Type (2021-2032)
5 Medical AI-assisted Diagnosis Solution Market by Application
- 5.1 Medical AI-assisted Diagnosis Solution Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Imaging Center
- 5.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Application
- 5.2.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Application (2021-2032)
- 5.2.3 Global Medical AI-assisted Diagnosis Solution Sales Value Share by Application (2021-2032)
6 Medical AI-assisted Diagnosis Solution Regional Value Analysis
- 6.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Region (2021-2032)
- 6.2.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Region: 2021-2026
- 6.2.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical AI-assisted Diagnosis Solution Sales Value (2021-2032)
- 6.3.2 North America Medical AI-assisted Diagnosis Solution Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical AI-assisted Diagnosis Solution Sales Value (2021-2032)
- 6.4.2 Europe Medical AI-assisted Diagnosis Solution Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical AI-assisted Diagnosis Solution Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical AI-assisted Diagnosis Solution Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical AI-assisted Diagnosis Solution Sales Value (2021-2032)
- 6.6.2 South America Medical AI-assisted Diagnosis Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical AI-assisted Diagnosis Solution Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical AI-assisted Diagnosis Solution Sales Value Share by Country, 2025 VS 2032
7 Medical AI-assisted Diagnosis Solution Country-level Value Analysis
- 7.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Country (2021-2032)
- 7.2.1 Global Medical AI-assisted Diagnosis Solution Sales Value by Country (2021-2026)
- 7.2.2 Global Medical AI-assisted Diagnosis Solution Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical AI-assisted Diagnosis Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical AI-assisted Diagnosis Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical AI-assisted Diagnosis Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sense Time
- 8.1.1 Sense Time Company Information
- 8.1.2 Sense Time Business Overview
- 8.1.3 Sense Time Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.1.4 Sense Time Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.1.5 Sense Time Recent Developments
- 8.2 United Imaging
- 8.2.1 United Imaging Company Information
- 8.2.2 United Imaging Business Overview
- 8.2.3 United Imaging Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.2.4 United Imaging Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.2.5 United Imaging Recent Developments
- 8.3 Huiying Medical
- 8.3.1 Huiying Medical Company Information
- 8.3.2 Huiying Medical Business Overview
- 8.3.3 Huiying Medical Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.3.4 Huiying Medical Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.3.5 Huiying Medical Recent Developments
- 8.4 Yizhun
- 8.4.1 Yizhun Company Information
- 8.4.2 Yizhun Business Overview
- 8.4.3 Yizhun Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.4.4 Yizhun Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.4.5 Yizhun Recent Developments
- 8.5 BioMind
- 8.5.1 BioMind Company Information
- 8.5.2 BioMind Business Overview
- 8.5.3 BioMind Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.5.4 BioMind Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.5.5 BioMind Recent Developments
- 8.6 Shukun
- 8.6.1 Shukun Company Information
- 8.6.2 Shukun Business Overview
- 8.6.3 Shukun Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.6.4 Shukun Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.6.5 Shukun Recent Developments
- 8.7 Lepu Medical
- 8.7.1 Lepu Medical Company Information
- 8.7.2 Lepu Medical Business Overview
- 8.7.3 Lepu Medical Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.7.4 Lepu Medical Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.7.5 Lepu Medical Recent Developments
- 8.8 Infervision
- 8.8.1 Infervision Company Information
- 8.8.2 Infervision Business Overview
- 8.8.3 Infervision Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.8.4 Infervision Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.8.5 Infervision Recent Developments
- 8.9 NeuMiva
- 8.9.1 NeuMiva Company Information
- 8.9.2 NeuMiva Business Overview
- 8.9.3 NeuMiva Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.9.4 NeuMiva Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.9.5 NeuMiva Recent Developments
- 8.10 Baidu Lingyi
- 8.10.1 Baidu Lingyi Company Information
- 8.10.2 Baidu Lingyi Business Overview
- 8.10.3 Baidu Lingyi Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.10.4 Baidu Lingyi Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.10.5 Baidu Lingyi Recent Developments
- 8.11 Tencent Health
- 8.11.1 Tencent Health Company Information
- 8.11.2 Tencent Health Business Overview
- 8.11.3 Tencent Health Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.11.4 Tencent Health Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.11.5 Tencent Health Recent Developments
- 8.12 Deepwise
- 8.12.1 Deepwise Company Information
- 8.12.2 Deepwise Business Overview
- 8.12.3 Deepwise Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.12.4 Deepwise Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.12.5 Deepwise Recent Developments
- 8.13 VoxelCloud
- 8.13.1 VoxelCloud Company Information
- 8.13.2 VoxelCloud Business Overview
- 8.13.3 VoxelCloud Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.13.4 VoxelCloud Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.13.5 VoxelCloud Recent Developments
- 8.14 Wision
- 8.14.1 Wision Company Information
- 8.14.2 Wision Business Overview
- 8.14.3 Wision Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.14.4 Wision Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.14.5 Wision Recent Developments
- 8.15 ZHENHEALTH
- 8.15.1 ZHENHEALTH Company Information
- 8.15.2 ZHENHEALTH Business Overview
- 8.15.3 ZHENHEALTH Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.15.4 ZHENHEALTH Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.15.5 ZHENHEALTH Recent Developments
- 8.16 G K Healthcare
- 8.16.1 G K Healthcare Company Information
- 8.16.2 G K Healthcare Business Overview
- 8.16.3 G K Healthcare Medical AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
- 8.16.4 G K Healthcare Medical AI-assisted Diagnosis Solution Product Portfolio
- 8.16.5 G K Healthcare Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst